Felycin®-CA1 is now available by prescription via licensed veterinarians, and PBI-Gordon Companies, Inc. confirms that it has no affiliation with any online companies offering rapamycin (sirolimus) through telehealth consultations. PBI-Gordon Companies, Inc. the parent company of TriviumVet, holds sole conditional approval from the FDA for Felycin®-CA1 (sirolimus delayed-release tablets) sold under the PRN Pharmacal brand of its affiliated company Pegasus.
Source: businesswire, July 30, 2025. Link. Felycin®-CA1 is a specifically designed dosage formulation of sirolimus comprising an enteric coated delayed-release technology that results in a specific pharmacokinetic profile to ensure both the safety and effectiveness of Felycin®-CA1 for cats with HCM.